IART stock news · Integra LifeSciences Holdings Corporation
Get alerts for IART
Follow Integra LifeSciences Holdings Corporation (IART) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IARTTruist lowered its price goal for Integra LifeSciences to $13, down from $15.
Bad for IARTIntegra LifeSciences saw Truist lower its price target after third-quarter results, while keeping a Hold rating. The cut signals a less favorable view of its shares.
Integra Lifesciences shares what happened during their earnings call for the third quarter of 2026.
Bad for IARTIntegra’s sales reached $411 million, but flood disruption and weaker Tissue Reconstruction led to a lower 2026 forecast. That points to a weaker business outlook.
Integra LifeSciences shares how they did financially in the third quarter of 2026.
NeutralIntegra announced quarterly results and a company forecast, but this excerpt gives no figures for sales or profit. It also excludes several costs from adjusted measures, so the story does not show whether business improved.
12 health care stocks are changing a lot before the market opens on Tuesday.
NeutralIntegra LifeSciences shares rose 31.97% in Tuesday premarket trading, but the article gives no company news behind the rise. It does not change the company's outlook.
Integra LifeSciences Holdings Corp has signed an important agreement with lenders.
NeutralIntegra LifeSciences closed a credit agreement and notes sale, but the filing gives no amount or cost. The available terms do not show a clear change for the company.
Integra LifeSciences is changing its 2026 plans because of damage from flooding.
Bad for IARTIART cut its 2026 sales and profit forecasts after flood damage disrupted a key plant. Insurance should cover much of the cost, but lost sales and lengthy repairs weaken its outlook.
On Friday, 12 health care stocks changed a lot in price during the day.
NeutralIntegra Lifesciences' shares fell 19.89% during Friday's session. The article gives no company news behind the drop, so it does not change the business outlook.
Integra LifeSciences shares new info about plans to refinance its loans in 2026.
NeutralIntegra LifeSciences Holdings Corporation filed a Form 8-K with the SEC, providing an updated investor presentation related to its plans to refinance its outstanding senior credit facility in 2026.